MNKDSMALL

MannKind Corporation

HealthcareBiotechnology
$4.22
$0.00(-1.17%)
52W$2.23
$6.51
Updated Jul 8, 02:00 AM
RSI61
RS Rating80/99
Beta1.07
Volatility74%
F-Score4/9
Mkt Cap$1.3B
CONSOLIDATING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

CONSOLIDATING

MannKind Corporation is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is leading (RS Rating: 80), indicating clear outperformance against the broad market. Earnings contraction of 231% provides fundamental context to the price action. However, price is extended 20% above the 50-day line, increasing the risk of a mean reversion.

Relative Strength
80
out of 99
Market Leader
Trend Score
2/4
Minervini Criteria
CONSOLIDATING
Risk (Beta)
1.07
vs S&P 500
MARKET
52W Position
46%
from 52W low
Lower Half
Trend & Momentum Analysis

Trend Template (Minervini)

CONSOLIDATING2/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$3.51
50 SMA > 100 SMA$3.36
100 SMA > 150 SMA$4.15
150 SMA > 200 SMA$4.46

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$3.95+6.81%ABOVE
50 SMA$3.51+20.13%ABOVE
100 SMA$3.36+25.54%ABOVE
150 SMA$4.15+1.57%ABOVE
200 SMA$4.46-5.36%BELOW

Price Performance

1D-1.2%
1W-0.9%
1M+24.5%
3M+64.2%
6M-27.9%
YTD-24.6%
1Y+19.2%
3Y+2.6%
52-Week Trading Range46% from low
$4.22
52W Low$2.23
52W High$6.51

Technical Indicators

RSI (14)BULLISH
61.3
305070
Setup ScoreCOOL
4/10
Base depth: 47.4%

Risk Profile

Beta
1.07
52W Vol
74%
ATR
$0.22
Max DD (1Y)
-63%

Volume Analysis

Today
3.36M
50D Avg
5.66M
Vol Ratio
0.59x
Liquidity
MODERATE

Earnings Momentum

Q2'25+128%
$0.00
Q3'25-37%
$0.03
Q4'25-292%
$-0.05
Q1'26-231%
$-0.05
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:+39.89%
3 Years:+51.80%
TTM:+21.23%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:-175.43%

Stock Price CAGR

10 Years:-2.96%
5 Years:-3.30%
3 Years:+2.58%
1 Year:+19.21%

Return on Equity

10Y Avg:
5Y Avg:
3Y Avg:
Last Year:

Key Metrics

Market Cap$1.3B
Gross Margin82.5%
Net Margin1.7%
Piotroski F-Score4/9

Frequently Asked Questions

Is MNKD in an uptrend right now?

MNKD has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.

Is MNKD overbought or oversold?

MNKD's RSI (14) is 61. The stock is in neutral territory, neither overbought nor oversold.

Is MNKD outperforming the market?

MNKD has a Relative Strength (RS) Rating of 80 out of 99. Yes, MNKD is a market leader, outperforming 80% of all stocks over the past 12 months.

Where is MNKD in its 52-week range?

MNKD is trading at $4.22, which is 65% of its 52-week high ($6.51) and 46% above its 52-week low ($2.23).

How volatile is MNKD?

MNKD has a Beta of 1.07 and 52-week volatility of 74%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.